Brief: Cytodyn Seeks UK Approval Of Leronlimab For HIV And Covid-19
07/08/2020 06:16
Aug 7 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN SEEKS UK APPROVAL OF LERONLIMAB FOR HIV AND
COVID-19
* WILL SUBSEQUENTLY PREPARE REQUESTS FOR PRE-SUBMISSION
MEETINGS
IN EUROPEAN UNION MEMBER COUNTRIES
Source text for Eikon: ID:nGNX9Fq8pz
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer